An interventional study of Investigate efficacy of modified ciat schedule and examine the efficacy of standard treatment versus modified ciat schedule in Aphasia, sponsored by NRZ Magdeburg Median Kliniken GmbH & Co. Completed at 1 site in Germany. Open to participants aged 34 Years to 84 Years. Per ClinicalTrials.gov, last updated 2012-06-21.
Sponsored by NRZ Magdeburg Median Kliniken GmbH & Co · Not applicable, Interventional, and Treatment
The purpose of this study is to assess the feasibility of modified Constraint-Induced Aphasia Therapy (CIAT) in the early sub-acute stage and to examine the efficacy of modified CIAT versus standard treatment with the same intensity of intervention.
365 studies on the registry are indexed under Aphasia; 89 are open to participants now.
This study's enrollment of 100 is above the median of 30 across 316 interventional studies indexed under Aphasia.
Browse Aphasia studies →This is the only study on the registry with NRZ Magdeburg Median Kliniken GmbH & Co as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients received a modified constraint-induced therapy schedule
Other: Investigate efficacy of modified ciat schedule
patients received a standard aphasia therapy
Other: examine the efficacy of standard treatment versus modified ciat schedule
2 hours of training over 15 days
2 hours of training over 15 days
Change of aphasia and aphasic syndromes by Aachen Aphasia Test (AAT)
Time frame: pretreatment and 4 weeks
change from pretreatment in Aachen Aphasia Test at 8 weeks
Time frame: pretreatment and 8 weeks
change from pretreatment in Aachen Aphasia Test at 1 year
Time frame: pretreatment and 1 year
Change of Communicative Activity (CAL)
Time frame: pretreatment and 4 weeks
change from pretreatment in communication activity (CAL)at 8 weeks
Time frame: pretreatment and 8 weeks
Change from pretreatment in communication activity (CAL)at 1 year
Time frame: pretreatment and 1 year
This study is completed, as verified in Jun 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.